These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1125 related articles for article (PubMed ID: 32775021)

  • 1. A Case of Paraneoplastic Myoclonus Attributed to Non-Small Cell Lung Cancer.
    Nichols JL; Lee BJ; Chung KA
    Tremor Other Hyperkinet Mov (N Y); 2020 Jun; 10():7. PubMed ID: 32775021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term survival in paraneoplastic opsoclonus-myoclonus syndrome associated with small cell lung cancer.
    Hassan KA; Kalemkerian GP; Trobe JD
    J Neuroophthalmol; 2008 Mar; 28(1):27-30. PubMed ID: 18347455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraneoplastic Opsoclonus-Myoclonus Syndrome: initial presentation of non-Hodgkins lymphoma.
    Kumar A; Lajara-Nanson WA; Neilson RW
    J Neurooncol; 2005 May; 73(1):43-5. PubMed ID: 15933816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraneoplastic Encephalitis and Enteric Neuropathy Associated With Anti-Hu Antibody in a Patient Following Immune-checkpoint Inhibitor Therapy.
    Kang K; Zheng K; Zhang Y
    J Immunother; 2020 Jun; 43(5):165-168. PubMed ID: 32195750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential fluctuating paraneoplastic ocular flutter-opsoclonus-myoclonus syndrome and Lambert-Eaton myasthenic syndrome in small-cell lung cancer.
    Simister RJ; Ng K; Lang B; Beckles M; Chao D; McCabe DJ
    J Neurol Neurosurg Psychiatry; 2011 Mar; 82(3):344-6. PubMed ID: 20392978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraneoplastic neurological disorders.
    Blaes F; Tschernatsch M
    Expert Rev Neurother; 2010 Oct; 10(10):1559-68. PubMed ID: 20925471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small cell lung cancer presenting with paraneoplastic limbic encephalitis.
    Bowyer S; Webb S; Millward M; Jasas K; Blacker D; Nowak A
    Asia Pac J Clin Oncol; 2011 Jun; 7(2):180-4. PubMed ID: 21585699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ANNA-2: an antibody associated with paraneoplastic opsoclonus in a patient with large-cell carcinoma of the lung with neuroendocrine features--correlation of clinical improvement with tumor response.
    Erlich R; Morrison C; Kim B; Gilbert MR; Alrajab S
    Cancer Invest; 2004; 22(2):257-61. PubMed ID: 15199608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Opsoclonus-myoclonus: paraneoplastic syndrome associated with renal adenocarcinoma].
    Gimeno Campos MJ; Sanchis Mínguez C; Díez de Diego P; Sánchez Villasante J
    Rev Esp Anestesiol Reanim; 2006 Jan; 53(1):54-5. PubMed ID: 16475641
    [No Abstract]   [Full Text] [Related]  

  • 10. Paraneoplastic Opsoclonus-myoclonus Syndrome with Anti-Hu and Anti-SOX-1 Antibodies after Immune-checkpoint Inhibitor Treatment Combined with Chemotherapy in a Patient with Small-cell Lung Cancer.
    Arai H; Utsu Y; Horio J; Furukawa S; Kikkawa Y
    Intern Med; 2022; 61(1):71-74. PubMed ID: 34980760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus.
    Bataller L; Graus F; Saiz A; Vilchez JJ;
    Brain; 2001 Feb; 124(Pt 2):437-43. PubMed ID: 11157570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult paraneoplastic opsoclonus-myoclonus syndrome associated with antimitochondrial autoantibodies.
    Blaes F; Jauss M; Kraus J; Oschmann P; Krasenbrink I; Kaps M; Teegen B
    J Neurol Neurosurg Psychiatry; 2003 Nov; 74(11):1595-6. PubMed ID: 14617731
    [No Abstract]   [Full Text] [Related]  

  • 13. [Paraneoplastic opsoclonus-myoclonus syndrome associated with small-cell lung cancer].
    Margery J; Ferroir JP; Epaud C; Martin C; Milleron B
    Rev Pneumol Clin; 2003 Nov; 59(5 Pt 1):321-4. PubMed ID: 14707930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance therapy with pemetrexed and bevacizumab versus pemetrexed monotherapy after induction therapy with carboplatin, pemetrexed, and bevacizumab in patients with advanced non-squamous non small cell lung cancer.
    Karayama M; Inui N; Fujisawa T; Enomoto N; Nakamura Y; Kuroishi S; Yokomura K; Koshimizu N; Sato M; Toyoshima M; Shirai T; Masuda M; Yamada T; Imokawa S; Suda T
    Eur J Cancer; 2016 May; 58():30-7. PubMed ID: 26922170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal paraneoplastic limbic encephalitis presenting as orgasmic epilepsy.
    Fadul CE; Stommel EW; Dragnev KH; Eskey CJ; Dalmau JO
    J Neurooncol; 2005 Apr; 72(2):195-8. PubMed ID: 15926002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study.
    Langer CJ; Gadgeel SM; Borghaei H; Papadimitrakopoulou VA; Patnaik A; Powell SF; Gentzler RD; Martins RG; Stevenson JP; Jalal SI; Panwalkar A; Yang JC; Gubens M; Sequist LV; Awad MM; Fiore J; Ge Y; Raftopoulos H; Gandhi L;
    Lancet Oncol; 2016 Nov; 17(11):1497-1508. PubMed ID: 27745820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Non-Squamous Non-Small-Cell Lung Cancer.
    Wakelee H; Zvirbule Z; De Braud F; Kingsley CD; Mekhail T; Lowe T; Schütte W; Lena H; Lawler W; Braiteh F; Cosgriff T; Kaen D; Boyer M; Hsu J; Phan S; Novello S
    Clin Lung Cancer; 2017 Jan; 18(1):50-59. PubMed ID: 27856142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary lateral sclerosis and lung adenocarcinoma].
    Martinez L; Lamaze R; Clément-Duchêne C
    Rev Mal Respir; 2013 Mar; 30(3):227-30. PubMed ID: 23497933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurologic paraneoplastic syndrome with anti-CV2/CRMP5 antibodies revealing a small cell lung cancer. Effectiveness of the lung cancer treatment].
    Rosencher L; Maisonobe T; Lavole A; Milleron B; Ferroir JP
    Rev Neurol (Paris); 2012 Apr; 168(4):371-4. PubMed ID: 22387203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of carboplatin, pemetrexed, and bevacizumab followed by erlotinib and bevacizumab maintenance for non-squamous non-small cell lung cancer with wild-type EGFR (HOT1101).
    Takashina T; Asahina H; Oizumi S; Yamada N; Harada M; Takamura K; Yokouchi H; Harada T; Honjo O; Ogi T; Morikawa N; Kinoshita I; Honda R; Nakano K; Kanazawa K; Amano T; Dosaka-Akita H; Isobe H; Nishimura M;
    Int J Clin Oncol; 2018 Dec; 23(6):1060-1069. PubMed ID: 30027464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.